Boca HBVIg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Boca HBVIg, covering 2019-01-22 to 2019-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation [Phase 1, Phase 2]